Cheryl Gregory-Evans Bsc.,Ph.D. from Canada, Associate Professor in Ophthalmology, Department of Ophthalmology and Visual Sciences University of British Columbia Eye Care Center. Her research interest over the past 20 years has been in the identification of molecular and cellular defects causing eye disease, principally affecting the retina and more recently affecting eye development in conditions such as ocular coloboma and aniridia. She presented report "Pre-clinical development of START (Sodium chloride, Tween 80, Ataiuren, caRboxyme, Thylcellulose) therapy in a mouse model of aniridia" .
